IBDEI1JR ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25862,2)
 ;;=^5014641
 ;;^UTILITY(U,$J,358.3,25863,0)
 ;;=M79.89^^127^1266^142
 ;;^UTILITY(U,$J,358.3,25863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25863,1,3,0)
 ;;=3^Soft Tissue Disorders NEC
 ;;^UTILITY(U,$J,358.3,25863,1,4,0)
 ;;=4^M79.89
 ;;^UTILITY(U,$J,358.3,25863,2)
 ;;=^5013357
 ;;^UTILITY(U,$J,358.3,25864,0)
 ;;=I73.9^^127^1266^131
 ;;^UTILITY(U,$J,358.3,25864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25864,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25864,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,25864,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,25865,0)
 ;;=I80.13^^127^1266^132
 ;;^UTILITY(U,$J,358.3,25865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25865,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Bilateral Femoral Vein
 ;;^UTILITY(U,$J,358.3,25865,1,4,0)
 ;;=4^I80.13
 ;;^UTILITY(U,$J,358.3,25865,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,25866,0)
 ;;=I80.213^^127^1266^133
 ;;^UTILITY(U,$J,358.3,25866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25866,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Bilateral Iliac Vein
 ;;^UTILITY(U,$J,358.3,25866,1,4,0)
 ;;=4^I80.213
 ;;^UTILITY(U,$J,358.3,25866,2)
 ;;=^5007833
 ;;^UTILITY(U,$J,358.3,25867,0)
 ;;=I80.12^^127^1266^135
 ;;^UTILITY(U,$J,358.3,25867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25867,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Left Femoral Vein
 ;;^UTILITY(U,$J,358.3,25867,1,4,0)
 ;;=4^I80.12
 ;;^UTILITY(U,$J,358.3,25867,2)
 ;;=^5007826
 ;;^UTILITY(U,$J,358.3,25868,0)
 ;;=I80.212^^127^1266^136
 ;;^UTILITY(U,$J,358.3,25868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25868,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Left Iliac Vein
 ;;^UTILITY(U,$J,358.3,25868,1,4,0)
 ;;=4^I80.212
 ;;^UTILITY(U,$J,358.3,25868,2)
 ;;=^5007832
 ;;^UTILITY(U,$J,358.3,25869,0)
 ;;=I80.11^^127^1266^138
 ;;^UTILITY(U,$J,358.3,25869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25869,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Right Femoral Vein
 ;;^UTILITY(U,$J,358.3,25869,1,4,0)
 ;;=4^I80.11
 ;;^UTILITY(U,$J,358.3,25869,2)
 ;;=^5007825
 ;;^UTILITY(U,$J,358.3,25870,0)
 ;;=I80.211^^127^1266^139
 ;;^UTILITY(U,$J,358.3,25870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25870,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Right Iliac Vein
 ;;^UTILITY(U,$J,358.3,25870,1,4,0)
 ;;=4^I80.211
 ;;^UTILITY(U,$J,358.3,25870,2)
 ;;=^5007831
 ;;^UTILITY(U,$J,358.3,25871,0)
 ;;=I80.203^^127^1266^134
 ;;^UTILITY(U,$J,358.3,25871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25871,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Bilateral Lower Extrem Deep Vessels
 ;;^UTILITY(U,$J,358.3,25871,1,4,0)
 ;;=4^I80.203
 ;;^UTILITY(U,$J,358.3,25871,2)
 ;;=^5007830
 ;;^UTILITY(U,$J,358.3,25872,0)
 ;;=I80.202^^127^1266^137
 ;;^UTILITY(U,$J,358.3,25872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25872,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Left Lower Extrem Deep Vessels
 ;;^UTILITY(U,$J,358.3,25872,1,4,0)
 ;;=4^I80.202
 ;;^UTILITY(U,$J,358.3,25872,2)
 ;;=^5007829
 ;;^UTILITY(U,$J,358.3,25873,0)
 ;;=I80.201^^127^1266^140
 ;;^UTILITY(U,$J,358.3,25873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25873,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis of Right Lower Extrem Deep Vessels
 ;;^UTILITY(U,$J,358.3,25873,1,4,0)
 ;;=4^I80.201
 ;;^UTILITY(U,$J,358.3,25873,2)
 ;;=^5007828
 ;;^UTILITY(U,$J,358.3,25874,0)
 ;;=I73.00^^127^1266^141
 ;;^UTILITY(U,$J,358.3,25874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25874,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,25874,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,25874,2)
 ;;=^5007796
